title: Is there a role for pharmacogenetics in the dosing of fentanyl?
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
authors.forename: Stijn Lw
authors.initials: SL
authors.lastname: Koolen
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.|Netherlands Comprehensive Cancer Organisation, The Netherlands.
authors.forename: Carin Cd
authors.initials: CC
authors.lastname: Van der Rijt
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000072716:Cancer Pain / Q000188:drug therapy* / Q000235:genetics*; D005283:Fentanyl / Q000008:administration & dosage*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods
chemical_list: D000701:Analgesics, Opioid; D005283:Fentanyl
keywords: fentanyl; pharmacogenetics; pharmacogenomics